The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Risk of anaphylaxis after vaccination of children and adolescents.
Abstract
OBJECTIVE: To quantify the risk of anaphylaxis after vaccination of children and adolescents. METHODS: The study population consisted of children and adolescents who were enrolled at 4 health maintenance organizations that participated in the Vaccine Safety Datalink Project. For the period 1991-1997, we identified potential cases by searching for occurrences of International Classification of Diseases, Ninth Revision (ICD-9) code 995.0 (anaphylactic shock), E948.0 through E948.9 (adverse reaction from bacterial vaccines), and E949.0 through E949.9 (adverse reaction from other vaccines and biological substances). At 1 study site, we also included a range of other allergy codes. We restricted to diagnoses on days 0 to 2 after vaccination (ICD-9 995.0) or day 0 (all other ICD-9 codes). We then reviewed the medical record to confirm the diagnosis. RESULTS: We identified 5 cases of potentially vaccine-associated anaphylaxis after administration of 7 644 049 vaccine doses, for a risk of 0.65 cases/million doses (95% confidence interval: 0.21-1.53). None of the episodes resulted in death. Vaccines that were administered before the anaphylactic episodes were generally given in combination and included measles-mumps-rubella, hepatitis B, diphtheria-tetanus, diphtheria-tetanus-pertussis, Haemophilus influenzae type b, and oral polio vaccine. One case of anaphylaxis followed measles-mumps-rubella vaccine alone. At the site at which we reviewed additional allergy codes, we identified 1 case after 653 990 vaccine doses, for a risk of 1.53 cases/million doses (95% confidence interval: 0.04-8.52). CONCLUSIONS: Patients and health care providers can be reassured that vaccine-associated anaphylaxis is a rare event. Nevertheless, providers should be prepared to provide immediate medical treatment should it occur.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For each 1.1 million doses of vaccine administered, approximately one recipient will experience this type of reaction (1328); however, no deaths have been reported among these patients (1318,1328).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1328]
Citations
Cites
Epidemiology and Prevention of Vaccine-Preventable Diseases
Atkinson, W. W. (2009) · Cited by 1,862
Allergy: Principles and Practice.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-817_10 · Cited by 1,698
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · Cited by 1,302
The Vaccine Adverse Event Reporting System (VAERS)
CHEN, R., RASTOGI, S., MULLEN, J., HAYES, S., COCHI, S., DONLON, J., & WASSILAK, S. (1994) · Vaccine · doi:10.1016/0264-410x(94)90315-8 · Cited by 498
The Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Postlicensure Safety Surveillance for Varicella Vaccine
Wise, R. P. (2000) · JAMA · doi:10.1001/jama.284.10.1271 · Cited by 214
Adverse Events Associated with Childhood Vaccines
Institute of Medicine (1994) · National Academies Press eBooks · doi:10.17226/2138 · Cited by 214
Patja, A., Davidkin, I., Kurki, T., KALLIO, M. J. T., Valle, M., & Peltola, H. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200012000-00002 · Cited by 193
A 7-YEAR SURVEY OF DISORDERS ATTRIBUTED TO VACCINATION IN NORTH WEST THAMES REGION
Pollock, T. M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92037-8 · Cited by 156
Underreporting of anaphylaxis in a community emergency room
Klein, J. S., & Yocum, M. W. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70329-2 · Cited by 153
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 322
O’Hagan, D. T., & Rappuoli, R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03234-9 · Cited by 31
Impfungen bei rheumatischen Erkrankungen des Kindes- und Jugendalters
Minden, K., Niewerth, M., Borte, M., Singendonk, W., & Haas, J. (2007) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-007-0150-z · Cited by 31
Schneider, G., Kachroo, S., Jones, N. B., Crean, S. M., Rotella, P., Avetisyan, R., & Reynolds, M. W. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2327 · Cited by 30
Moro, P. L., Leung, J. W. T., Marquez, P. L., Kim, Y., Wei, S., Su, J. R., & Marin, M. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac306 · Cited by 30
Comments on cow’s milk allergy and diphtheria, tetanus, and pertussis vaccines
Slater, J. E., Rabin, R. L., & Martin, D. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.028 · Cited by 30
Lemstra, M., Rajakumar, D., Thompson, A. T., & Moraros, J. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.1.e1 · Cited by 29
Jackson, L. A., Yu, O., Belongia, E. A., Hambidge, S. J., Nelson, J. C., Baxter, R. P., Naleway, A. L., Gay, C., Nordin, J. D., Baggs, J. M., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-165 · Cited by 29
Vaccine-Related Adverse Events in Cuban Children, 1999–2008
Galindo, B., Díaz, D. C., Galindo, M., Pérez, A., & Saiz, J. (2012) · MEDICC Review · doi:10.37757/mr2012v14.n1.8 · Cited by 28
Vaccination in children with allergy to non active vaccine components
Franceschini, F., Bottau, P., Caimmi, S. M. E., Crisafulli, G., Liotti, L., Peroni, D. G., Saretta, F., Vernich, M., Dascola, C. P., & Caffarelli, C. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0043-0 · Cited by 27
The U.S. Food and Drug Administration's Mini‐Sentinel Program
Platt, R. G., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3230 · Cited by 27
Nøkleby, H. (2006) · Current Allergy and Asthma Reports · doi:10.1007/s11882-006-0003-x · Cited by 27
Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine – A Case Report
Drucker, A., Corrao, K., & Gandy, M. (2021) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2021.10.007 · Cited by 26
Zou, H., Chen, Y., Duan, Z., & Zhang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026748 · Cited by 26
Miller, E. R., Moro, P. L., Cano, M. V., Lewis, P., Bryant-Genevier, M. G., & Shimabukuro, T. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.021 · Cited by 26
Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
Iskander, J., & Broder, K. R. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.1.75 · Cited by 26
Stone, K. (2004) · Current opinion in pediatrics · doi:10.1097/01.mop.0000141917.63075.73 · Cited by 13
Seitz, C. S., Bröcker, E., & Trautmann, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.020 · Cited by 25
Spirito, F. D., Amato, A., Palo, M. P. D., Ferraro, R., Cannatà, D., Galdi, M., Sacco, E., & Amato, M. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15070175 · Cited by 24
Safety of yellow fever vaccine administration in confirmed egg-allergic patients
Gerhardt, C. M. B., Castro, A. P. B. M., Pastorino, A. C., Dorna, M. D. B., Nunes-Santos, C. D. J., Aquilante, B. P., Miyaji, K. T., & Lopes, M. H. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.020 · Cited by 24
An approach to death as an adverse event following immunization
Gold, M., Balakrishnan, M. R., Amarasinghe, A., & MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.11.018 · Cited by 26
Active Influenza Vaccine Safety Surveillance
Brown, J. S., Moore, K. M., Braun, M. M., Ziyadeh, N. J., Chan, K. A., Lee, G. M., Kulldorff, M., Walker, A. M., & Platt, R. G. (2009) · Medical Care · doi:10.1097/mlr.0b013e3181b58b5c · Cited by 24
Self-citationde Freitas, D. R. C., Moura, E., Araújo, G. C. B., Cardoso, A. V., Scheidt, P., Ferraz, E., Madalosso, G., Chen, R. T., & Hatch, D. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.095 · Cited by 23
Haber, P., Moro, P. L., Ng, C. S., Lewis, P. W., Hibbs, B. F., Schillie, S. F., Nelson, N. P., Li, R., Stewart, B., & Cano, M. V. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.11.079 · Cited by 23
Vaccine allergy evaluation and management at the specialized Green Channel Consultation Clinic
Micheletti, F., Peroni, D. G., PIACENTINI, G. L., Schweiger, V., Mirandola, R., Chiesa, E., & Zanoni, G. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.03985.x · Cited by 23
Cronin, J. J., Scorr, A., Russell, S., McCoy, S., Walsh, S., & O’Sullivan, R. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02737.x · Cited by 22
Lieberman, P. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e3283154e8e · Cited by 22
Koenig, H. C., Sutherland, A., Izurieta, H. S., & McGonagle, D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.044 · Cited by 22
Vaccine safety: current systems and recent findings
Wharton, M. E. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283350425 · Cited by 22
Ravanfar, P., Satyaprakash, A. K., Creed, R., & Mendoza, N. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2009.01224.x · Cited by 22
Anaphylaxis After Immunization of Children and Adolescents in Germany
Oberle, D., Pavel, J., Rieck, T., Weichert, S., Schroten, H., Keller‐Stanislawski, B., & Tenenbaum, T. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001073 · Cited by 20
Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study
Luyten, J., Dorgali, M. V., Hens, N., & Beutels, P. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.11.009 · Cited by 20
Vanlander, A., & Hoppenbrouwers, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.03.096 · Cited by 19
Falsas creencias sobre las vacunas
Domı́nguez, Á., Astray, J., Castilla, J., Godoy, P., Tuells, J., & Barrabeig, I. (2018) · Atención Primaria · doi:10.1016/j.aprim.2018.05.004 · Cited by 24
Tse, Y., & Rylance, G. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.120378 · Cited by 24
Monitoring vaccine safety during an influenza pandemic.
Iskander, J., Haber, P., & Herrera, G. (2005) · PubMed Central · Cited by 19
Anaphylaxis as an adverse event following immunisation: Table 1
Erlewyn‐Lajeunesse, M., Bonhoeffer, J., Rüggeberg, J. U., & Heath, P. T. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.037457 · Cited by 19
Diagnostic issues in pediatric drug allergy
Caubet, J., & Eigenmann, P. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328355b7b1 · Cited by 18
Huang, K. A., Tao, S., Zhou, X., Mo, J., Zhu, B., Shen, P., Lin, H., Arena, P. J., & He, N. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.03.013 · Cited by 18
Johann‐Liang, R., Josephs, S. H., & Dreskin, S. C. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.01.014 · Cited by 18
Mathias-Santos, C., Rodrigues, J. F., Sbrogio-Almeida, M. E., Connell, T. D., & Ferreira, L. C. D. S. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00012-11 · Cited by 17
Safety of the Yellow Fever Vaccine: A Retrospective Study
Nordin, J. D., Parker, E. D., Vazquez‐Benitez, G., Kharbanda, E. O., Naleway, A. L., Marcy, S. M., Molitor, B. A., Kuckler, L., & Baggs, J. M. (2013) · Journal of Travel Medicine · doi:10.1111/jtm.12070 · Cited by 17
Self-citationAnaphylaxis following H1N1 pandemic vaccines: Safety data in perspective
Silva, F. T. D., Delaigle, A., Slavin, D., Bauchau, V., Fries, L. F., & Seifert, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.026 · Cited by 16
Diagnosis and management of hypersensitivity reactions to vaccines
Sarti, L., Lezmi, G., Mori, F., Giovannini, M., & Caubet, J. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1814745 · Cited by 16
Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children
Muhammad, R. D., Haber, P., Broder, K. R., Leroy, Z. C., Ball, R., Braun, M. M., Davis, R. L., & McMahon, A. W. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181ff9795 · Cited by 15
Self-citationHaber, P., Arana, J., Pilishvili, T., Lewis, P., Moro, P. L., & Cano, M. V. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.052 · Cited by 15
Zafack, J. G., Serres, G. D., Rouleau, I., Gariépy, M.-C., Gagnon, R., Drolet, J., & Skowronski, D. M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.09.048 · Cited by 15
D’Errico, S., Neri, M., Riezzo, I., Rossi, G., Pomara, C., Turillazzi, E., & Fineschi, V. (2008) · Forensic Science International · doi:10.1016/j.forsciint.2008.04.018 · Cited by 15
Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use
Hansen, J. R., Yee, A., Lewis, N., Li, S., Velicer, C. M., Saddier, P., & Klein, N. P. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.11.009 · Cited by 15
Vaccine Allergy? Skin Testing and Challenge at a Tertiary Pediatric Hospital in Melbourne, Australia
Cheung, A. W., Choo, S., & Perrett, K. P. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.01.025 · Cited by 14
A Case of Anaphylaxis to Measles Vaccination in an Infant with Cow's Milk Allergy
Çimen, S. S., Özçeker, D., Gökçay, G., Güler, N., & Tamay, Z. (2019) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2019.0993 · Cited by 14
SchulerCHEO, J. E., King, W. J., Dayneka, N., Rastelli, L., Marquis, E., Chad, Z. H., & Hui, C. P. (2011) · Canadian Journal of Public Health · doi:10.1007/bf03404895 · Cited by 14
PCIRN Investigators, Top, K. A., Zafack, J. G., Serres, G. D., & Halperin, S. A. (2014) · Paediatrics & Child Health · doi:10.1093/pch/19.6.310 · Cited by 13
Nnamdi, O. A., Agu, R. U., Chinedum, O. U., Nwoye, C. U., Ejiofor, O. S., & Okechukwu, E. C. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(15)30157-x · Cited by 13
Assessing the safety of influenza vaccination in specific populations: children and the elderly
Rowhani‐Rahbar, A., Klein, N. P., & Baxter, R. P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.66 · Cited by 13
Hypersensitivity in Orthodontics: A Systematic Review of Oral and Extra-Oral Reactions
Amato, A., Martina, S., Benedetto, G. D., Michelotti, A., Amato, M., & Spirito, F. D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134766 · Cited by 12
Anaphylactic shock due to hepatitis B immunoglobulin in a newborn
Bülbül, A., Karadag, A., Köklü, E., Pamuk, U., & Sarıcı, S. Ü. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767051003653260 · Cited by 12
Does Food Allergy Require Any Change in Measles-Mumps-Rubella Vaccination?
Elitok, G. K., Çelikboya, E., Bülbül, L., Kaya, A., Toraman, T., Bülbül, A., & Uslu, S. (2019) · The Indian Journal of Pediatrics · doi:10.1007/s12098-019-02981-w · Cited by 12
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review
Alpalhão, M., Silva, J. M., & Filipe, P. (2021) · Dermatitis · doi:10.1097/der.0000000000000755 · Cited by 12
Anaphylaxis following single component measles and rubella immunisation
Erlewyn‐Lajeunesse, M., Manek, R., Lingam, R., Finn, A. H. R., & Emond, A. M. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2008.138289 · Cited by 12
Update on vaccination guidelines for allergic children
Kelso, J. M. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.107 · Cited by 12
Methodology for computing the burden of disease of adverse events following immunization
McDonald, S., Nijsten, D., Bollaerts, K., Bauwens, J., Praet, N., van der Sande, M. A. B., Bauchau, V., Smedt, T. D., Sturkenboom, M., & Hahné, S. J. M. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4419 · Cited by 12
Wu, D. (2019) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2019.08.009 · Cited by 12
Dermal testing of vaccines for children at high risk of allergies
Sugai, K., Shiga, A., Okada, K., Iwata, T., Ogura, H., Maekawa, K., & Yokota, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.057 · Cited by 12
Gender Differences in Immediate Hypersensitivity Reactions to Vaccines: A Review of the Literature
Griffioen, M. A., & Halsey, N. A. (2013) · Public Health Nursing · doi:10.1111/phn.12073 · Cited by 11
Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination
Ohmit, S. E., Gross, J., Victor, J. C., & Monto, A. S. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.100 · Cited by 11
Les réactions d’hypersensibilité allergique et non allergique aux vaccins contenant des anatoxines
Ponvert, C. (2009) · Archives de Pédiatrie · doi:10.1016/j.arcped.2009.01.002 · Cited by 11
Zalc, S., Lemos, P. A., Esteves, A., Ribeiro, E. E., Horta, P., Nicolau, J. C., Ramires, J. A. F., Cohen, M., & Martinez, E. E. (2006) · PubMed · Cited by 11
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data
Almohaya, A. M., Alsubie, H., Alqarni, B. A., Alzayad, B., Alghar, A., Alshahrani, K. A., & Barry, M. A. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.12.001 · Cited by 10
Adverse Reactions to Vaccines for Infectious Diseases
Kelso, J. M., & Greenhawt, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00086-3 · Cited by 10
Kuder, M. M., Lang, D. M., & Patadia, D. D. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.ccc075 · Cited by 10
Mast, E. E., & Ward, J. W. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50017-9 · Cited by 10
Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients
Gawryś, A., Gołębiowski, T., Zielińska, D., Augustyniak‐Bartosik, H., Kuriata-Kordek, M., Szenborn, L., & Krajewska, M. (2021) · Vaccines · doi:10.3390/vaccines9020077 · Cited by 9
Hall, G. C., Douglas, I., Heath, P. T., Prabhakar, P., Rosillon, D., Khan, J., & Abbing‐Karahagopian, V. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.065 · Cited by 9
Kollaritsch, H., & Rendi‐Wagner, P. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-1076-8.00009-0 · Cited by 9
Tillie‐Leblond, I., Magnan, A., Pauli, G., VERVLOET, D., Wallaert, B., Didier, A. P., Ameille, J., Godard, P., & the group of experts (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.03.002 · Cited by 9
Kaka, B., Ogwumike, O., & Adeniyi, A. F. (2011) · African Journal of Physiotherapy and Rehabilitation Sciences · doi:10.4314/ajprs.v3i1.4 · Cited by 8
Management of Anaphylaxis in Pediatric Population
Kuyucu, S., Arıkoğlu, T., & ÖZHAN, A. K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221021154032 · Cited by 8
Diphtheria boosters for adults: Balancing risks
Cameron, C., White, J. M., Power, D., & Crowcroft, N. S. (2006) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2006.02.001 · Cited by 8
L’asthme représente-t-il un facteur de risque de l’anaphylaxie ?
Vervloet, D., Rancé, F., Birnbaum, J., & Clément, O. (2007) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(07)73299-0 · Cited by 8
Implanting Military RFID: Rights and Wrongs
Nicholls, R. (2017) · IEEE Technology and Society Magazine · doi:10.1109/mts.2017.2654288 · Cited by 8
Anafilaxia relacionada à vacina sarampo, caxumba e rubéola, Santa Catarina, Brasil, 2014 e 2015
Fantinato, F. F. S. T., Vargas, A., Carvalho, S. M. D., Domingues, C. M. A. S., Barreto, G., Fialho, A. S., da Silva, R. H., Saad, E., & Agredo, I. N. S. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00043617 · Cited by 8
Huang, Z., Li, Y., Yi, H., Wu, Z., Li, C., Du, T., Yang, J., Wang, Y., Jiang, Q., Fan, S., et al. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2073889 · Cited by 7
Stefanizzi, P., Ferorelli, D., Scazzi, F. L., Lorenzo, A. D., Martinelli, A., Trinchera, C., Moscara, L., Miniello, E., Bona, D. D., & Tafuri, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074246 · Cited by 7
Uncertainties and Anxieties about Vaccination, Answering Parent's Concerns
Purssell, E. (2009) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2009.03.002 · Cited by 7
Jeimy, S. B., Wong, T., Ben‐Shoshan, M., Copaescu, A. M., Isabwe, G. A. C., & Ellis, A. K. (2025) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-024-00936-1 · Cited by 9
Lee, C., Gong, Y., Brok, J. S., Boxall, E. H., & Gluud, C. N. (2007) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.120 · Cited by 6
Common adverse drug reactions with psychiatric medications and an approach to their management
Szabo, C. P. (2011) · CME/Continuing medical education · Cited by 6
Impfen: Was tun bei bestehenden Allergien?
Schmidt, S. M. (2018) · Deutsches Ärzteblatt · doi:10.3238/perspneumo.2018.03.09.01 · Cited by 6
Moss, W. J., & Strebel, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00038-4 · Cited by 6
Vaccines and allergy: Back to the right places
Moschese, V., Montin, D., Ottaviano, G., Sgrulletti, M., Beni, A., Costagliola, G., Sangerardi, M., Santilli, V., del Giudice, M. M., Rizzo, C., et al. (2024) · Pediatric Allergy and Immunology · doi:10.1111/pai.14236 · Cited by 6
Recommendations for the Administration of Influenza Vaccine in Children Allergic to Egg
Reading, R. (2009) · Child Care Health and Development · doi:10.1111/j.1365-2214.2009.01063_2.x · Cited by 6
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Vellozzi, C. J. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch26 · Cited by 6
Neuhoff, B. K. (2025) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000938 · Cited by 6
Abbott, S. L., Etapelong, S. G., Gidado, S., Mawashi, K. Y., Edukugho, A. A., Hamisu, A. W., Abba, S., Adedire, E. B., Hassan, I. A., Waziri, N. E., et al. (2023) · Pan African Medical Journal · doi:10.11604/pamj.supp.2023.45.2.40228 · Cited by 5
When Should Vaccination Be Contraindicated in Children?
Lane, L., Reynolds, A. J., & Ramsay, M. E. (2005) · Drug Safety · doi:10.2165/00002018-200528090-00001 · Cited by 5
Épidémiologie de l'anaphylaxie pré-létale et létale
Moneret‐Vautrin, D. A., Flabbee, J., Morisset, M., Beaudouin, É., & Kanny, G. (2004) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/j.allerg.2004.01.006 · Cited by 5
Nicolosi, L., Vittucci, A. C., Mancini, R., Bozzola, E., Cagigi, A., Grandin, A., & Villani, A. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-40-31 · Cited by 5
Hall, E. W., Rosenberg, E. S., Trigg, M., Nelson, N. P., & Schillie, S. F. (2018) · Public Health Reports · doi:10.1177/0033354918768224 · Cited by 5
Vaccination against Haemophilus influenzae type b in the Russian Federation and Abroad
Озерецковский, Н. А., & Ивановна, Н. Т. (2016) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2016-15-1-61-66 · Cited by 5
Mesfin, Y. M., Cheng, A. C., Tran, A. H. L., & Buttery, J. P. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4877 · Cited by 5
Metadata
- Authors
- Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team
- Affiliations
- Group Health Cooperative (US)
- Kaiser Foundation Hospital (US)
- Center for Biologics Evaluation and Research (US)
- Centers for Disease Control and Prevention (US)
- Kaiser Permanente (US)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2003-10-01
- Volume
- 112
- Issue
- 4
- Pages
- 815-820
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2111371073
- Cited by
- 320
- References
- 24
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 5 · 2019: 14 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 17 · 2014: 16 · 2013: 14 · 2012: 25
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- vaccine anaphylaxis, vaccine safety, children and adolescents, MMR vaccine, hepatitis B vaccine, diphtheria-tetanus vaccine, Haemophilus influenzae type b vaccine, oral polio vaccine, vaccine adverse events, anaphylactic shock
- MeSH terms
- Adolescent, Anaphylaxis, California, Child, Child, Preschool, Female, Health Maintenance Organizations, Humans, Infant, Infant, Newborn, Male, Oregon, Risk, Vaccination, Vaccines, Washington, Cohort Studies, Adverse Drug Reaction Reporting Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review